Compare AMAR REMEDIES with Colgate - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs COLGATE - Comparison Results

COLGATE 
   Change

Colgate is present in oral care, personal care and household care products with oral care contributing more than 90% to overall revenues. Colgate dominates in this core business with market shares of 54.5% in toothpastes and 38.2% in toothbrushes. Th... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES COLGATE AMAR REMEDIES/
COLGATE
 
P/E (TTM) x -0.5 42.0 - View Chart
P/BV x 0.1 23.5 0.3% View Chart
Dividend Yield % 0.0 1.8 -  

Financials

 AMAR REMEDIES   COLGATE
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
COLGATE
Mar-19
AMAR REMEDIES/
COLGATE
5-Yr Chart
Click to enlarge
High Rs1641,365 12.0%   
Low Rs861,020 8.4%   
Sales per share (Unadj.) Rs261.6164.1 159.5%  
Earnings per share (Unadj.) Rs17.428.5 61.0%  
Cash flow per share (Unadj.) Rs22.334.4 64.8%  
Dividends per share (Unadj.) Rs023.00 0.0%  
Dividend yield (eoy) %01.9 0.0%  
Book value per share (Unadj.) Rs100.753.2 189.4%  
Shares outstanding (eoy) m26.16271.99 9.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.57.3 6.6%   
Avg P/E ratio x7.241.8 17.2%  
P/CF ratio (eoy) x5.634.7 16.2%  
Price / Book Value ratio x1.222.4 5.5%  
Dividend payout %080.7 0.0%   
Avg Mkt Cap Rs m3,270324,389 1.0%   
No. of employees `000NA2.3 0.0%   
Total wages/salary Rs m1632,959 5.5%   
Avg. sales/employee Rs ThNM19,359.8-  
Avg. wages/employee Rs ThNM1,283.7-  
Avg. net profit/employee Rs ThNM3,364.7-  
INCOME DATA
Net Sales Rs m6,84444,624 15.3%  
Other income Rs m21377 5.6%   
Total revenues Rs m6,86545,001 15.3%   
Gross profit Rs m1,13112,361 9.2%  
Depreciation Rs m1281,592 8.0%   
Interest Rs m39825 1,592.0%   
Profit before tax Rs m62611,121 5.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50305 -16.4%   
Tax Rs m1213,670 3.3%   
Profit after tax Rs m4557,756 5.9%  
Gross profit margin %16.527.7 59.7%  
Effective tax rate %19.333.0 58.6%   
Net profit margin %6.617.4 38.3%  
BALANCE SHEET DATA
Current assets Rs m4,90410,102 48.5%   
Current liabilities Rs m3,58110,511 34.1%   
Net working cap to sales %19.3-0.9 -2,106.9%  
Current ratio x1.41.0 142.5%  
Inventory Days Days12420 611.2%  
Debtors Days Days10017 583.7%  
Net fixed assets Rs m1,68913,896 12.2%   
Share capital Rs m262272 96.3%   
"Free" reserves Rs m2,35814,196 16.6%   
Net worth Rs m2,63514,468 18.2%   
Long term debt Rs m507777 65.2%   
Total assets Rs m6,86226,265 26.1%  
Interest coverage x2.6445.8 0.6%   
Debt to equity ratio x0.20.1 358.2%  
Sales to assets ratio x1.01.7 58.7%   
Return on assets %12.429.6 42.0%  
Return on equity %17.353.6 32.2%  
Return on capital %31.075.1 41.3%  
Exports to sales %4.00-   
Imports to sales %00-   
Exports (fob) Rs m273NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m2732,007 13.6%   
Fx outflow Rs m27,191 0.0%   
Net fx Rs m271-5,184 -5.2%   
CASH FLOW
From Operations Rs m-3139,830 -3.2%  
From Investments Rs m-489-957 51.0%  
From Financial Activity Rs m769-8,147 -9.4%  
Net Cashflow Rs m-33726 -4.5%  

Share Holding

Indian Promoters % 25.5 0.0 -  
Foreign collaborators % 0.0 51.0 -  
Indian inst/Mut Fund % 9.2 7.0 131.4%  
FIIs % 0.0 20.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 22.1 295.5%  
Shareholders   13,061 131,569 9.9%  
Pledged promoter(s) holding % 99.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   KARUTURI GLOBAL  MARICO  GODREJ INDUSTRIES  GODREJ CONSUMER  GILLETTE INDIA  

Compare AMAR REMEDIES With:   UNILEVER PLC. (UK)  P&G (US)  HYPERMARCAS (Brazil)  



Today's Market

Indian Indices End Lower, Manufacturing Activity Amid Lockdown, and Top Cues in Focus Today(Pre-Open)

Indian share markets witnessed selling pressure and ended lower on Friday. Selling came as market participants were worried about the economic impact.

Related Views on News

COLGATE Announces Quarterly Results (3QFY20); Net Profit Up 3.6% (Quarterly Result Update)

Jan 31, 2020 | Updated on Jan 31, 2020

For the quarter ended December 2019, COLGATE has posted a net profit of Rs 2 bn (up 3.6% YoY). Sales on the other hand came in at Rs 11 bn (up 4.3% YoY). Read on for a complete analysis of COLGATE's quarterly results.

COLGATE Announces Quarterly Results (2QFY20); Net Profit Up 24.3% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, COLGATE has posted a net profit of Rs 2 bn (up 24.3% YoY). Sales on the other hand came in at Rs 12 bn (up 3.9% YoY). Read on for a complete analysis of COLGATE's quarterly results.

COLGATE 2018-19 Annual Report Analysis (Annual Result Update)

Sep 30, 2019 | Updated on Sep 30, 2019

Here's an analysis of the annual report of COLGATE for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of COLGATE. Also includes updates on the valuation of COLGATE.

COLGATE Announces Quarterly Results (1QFY20); Net Profit Down 10.8% (Quarterly Result Update)

Jul 19, 2019 | Updated on Jul 19, 2019

For the quarter ended June 2019, COLGATE has posted a net profit of Rs 2 bn (down 10.8% YoY). Sales on the other hand came in at Rs 11 bn (up 4.2% YoY). Read on for a complete analysis of COLGATE's quarterly results.

COLGATE Announces Quarterly Results (4QFY19); Net Profit Up 4.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, COLGATE has posted a net profit of Rs 2 bn (up 4.7% YoY). Sales on the other hand came in at Rs 12 bn (up 5.7% YoY). Read on for a complete analysis of COLGATE's quarterly results.

More Views on News

Most Popular

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020(The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

A Big Trading Opportunity is Coming Your Way Soon(Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

One Stock that is All Charged Up for the Post Coronavirus Rebound(The 5 Minute Wrapup)

Apr 1, 2020

A stock with strong moat is currently trading near 5-year lows.

The Insiders See a Buying Opportunity in These Smallcaps Amid Coronavirus Outbreak(Profit Hunter)

Mar 31, 2020

The promoters are buying these smallcaps amid the coronavirus outbreak.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 8-QTR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS